Healio1d
FDA approves Evrysdi tablets for spinal muscular atrophy
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
The Lancet1d
Management of alcohol use disorder: a gastroenterology and hepatology-focused perspective
Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...
People Are Swapping Their Morning Coffee for Ginger Shots—Should You Try It?
Ginger shots have become a popular morning drink on social media. Our experts explain the real health benefits of ginger ...
pulmonologyadvisor4d
Cystic Fibrosis: GI Symptom Relief From ETI Wanes Over Long Term
In adults with cystic fibrosis, gastrointestinal symptoms initially improve with ETI but most do not consistently improve with longer-term use.
Daily6d
Dr. Reddy's Labs Gets CDSCO Panel Nod To Manufacture, Market Esomeprazole Gastro resistant capsules
This came after Dr. Reddy's Lab presented the proposal for grant of permission to manufacture and market Esomeprazole Gastro ...
MedPage Today6d
Risankizumab Tops Competitor for Clinical Remission in Moderate-to-Severe CD
SAN FRANCISCO -- More adults with moderate-to-severe Crohn's disease (CD) reached clinical remission after 6 months on ...